Cover of Clinical Review Report: Etonogestrel Extended-Release Subdermal Implant (Nexplanon)

Clinical Review Report: Etonogestrel Extended-Release Subdermal Implant (Nexplanon)

Merck Canada Inc.

Indication: For the Prevention of Pregnancy

CADTH Common Drug Review

Copyright © 2020 Canadian Agency for Drugs and Technologies in Health.
Read

The objective of this report was to perform a systematic review of the beneficial and harmful effects of radiopaque etonogestrel extended-release subdermal implant 68 mg (Nexplanon) for the prevention of pregnancy in women.